Abstract
Fibrous cap thickness (FCT) is the most important determinant of plaque stability. FCT is measured in vivo with optical coherence tomography (OCT). FCT is known to increase with maximized statin therapy. We used baseline transcriptomic data from the Yellow II clinical trial of rosuvastatin to
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
